Monday, December 6, 2010
Depuy Hip Replacement Cases Consolidated
In what was probably what was the worst kept secret in legal circles, the Judicial Panel on Multi-District Litigation assigned all Depuy ASR hip cases to United States District Judge Katz. The judge will supervise evidence gathering efforts regarding the hip implants which were recalled by Johnson and Johnson's Depuy Orthopedics unit on August 26th. According to Depuy, the implants were recalled after researchers found many patients needed revision surgery because of design defects. Recently, receipents have tested positive for toxic level of chromium and cobalt as a result of the implant failure.
Saturday, October 30, 2010
DePuy Hips -- Kickbacks, Deferred Prosecution and the role of Surgeons.

In 2007, DePuy avoided criminal prosecution over financial inducements paid to surgeons to use their hip and knee products by signing a Deferred Prosecution Agreement and paying civil settlements to the Departments of Justice and Health and Human Services of $84.7 million.
The Department of Justice alleged that DePuy routinely violated the anti-kickback statute by paying physicians to exclusively use their products. In announcing the settlement, United States Attorney Christopher J. Christie stated "prior to our investigation, many orthopedic surgeons in this country made decisions predicated on how much money they could make--choosing which device to implant by going to the highest bidder."
The government alleged that these agreements were in place between 2002-2006, which happens to be when many of the now recalled DePuy ASR hips were implanted. Government officials also stated that surgeons failed to disclose the payments to the hospitals where the surgeries were performed, and more importantly, to the patients the devices were installed.
As the DePuy litigation proceeds, both DePuy and some surgeons are going to have some difficult questions to answer.
Patients who return to the physicians who installed the recalled devices need to be aware these relationships exist, inquire of their physician as to whether or not they engaged in such kickback agreements and never let their physician influence them to sign releases allowing DePuy to obtain their medical records.
Friday, October 29, 2010
DePuy ASR XL Hip Implant Recall -- Frequently Asked Questions
If you or someone you know suffered pain and/or had to undergo additional surgery as a result of having the DEPUY Hip replacement, contact attorney Chris Hellums of Pittman, Dutton & Hellums today.
Johnson & Johnson's artificial joint replacement company DePuy Orthopaedics, Inc. has issued a recall of two hip replacement products because of high failure rates that necessitated second surgeries.
DePuy recalled the ASR XL Acetabular System and the ASR Hip Resurfacing System after data showed that within five years, one in eight patients (12%-13%) needed a "revision surgery," which is required when an artificial joint doesn't properly fit. Serious pain and difficulty walking can result from a faulty hip replacement. The "ASR" stands for articular surface replacements, meant to replace a damaged or diseased hip.
Johnson & Johnson's artificial joint replacement company DePuy Orthopaedics, Inc. has issued a recall of two hip replacement products because of high failure rates that necessitated second surgeries.
DePuy recalled the ASR XL Acetabular System and the ASR Hip Resurfacing System after data showed that within five years, one in eight patients (12%-13%) needed a "revision surgery," which is required when an artificial joint doesn't properly fit. Serious pain and difficulty walking can result from a faulty hip replacement. The "ASR" stands for articular surface replacements, meant to replace a damaged or diseased hip.
What Hip Replacement Products Have Been Recalled?
DEPUY has recalled the following hip replacement products:- ASR XL Acetabular System - was on the market since 2004 and sold worldwide.
- ASR Hip Resurfacing System - was on the market since 2003, and sold exclusive outside the United States.
How Can I Tell if I Have a Recalled Hip Device?
By now, your surgeon should have contacted you on behalf of DEPUY to notify you that your implant has been recalled. If not, and you are having the symptoms below, contact your physician or the hospital where the surgery was performed and request a copy of the "chart stick" from your surgery. Most likely, you have the ASR XL Acetabular System. The ASR XL Acetabular System is a 3 component system comprised of: the femoral stem (which is inserted inside the femur), the femoral head (or ball) that connects to the stem, and then fits inside the acetabulum (cup). A unique characteristic of the ASR XL Acetabular system is that it is a metal-on-metal device meaning both the ball and cup portion of the implant are metal.What are the Common Problems/Symptoms with the ASR Hips
Component loosening, component misalignment, infections, bone fractures, dislocation, loss of muscle mass, unexplained hip pain, thigh and groin pain, pain when walking or rising from seated position, and clicking sounds. X-rays can also reveal metal debris, which can ultimately lead to inflammation of the surrounding tissue.What Should I Do if I Received a Defective Hip Replacement
Always consult your doctor or physician regarding health-related issues, but if you or someone you care about received defective joint replacement components, we would like to speak with you right away. DO NOT SIGN A RELEASE FROM THE SURGEON OR DEPUY. It is imperative that you do NOT sign the release sent to you by your physician on behalf of DEPUY. These releases will allow DEPUY complete access to your medical records and allow them to obtain possession of the defective implant in the event it is removed.Who Discovered Problems and When?
The defects were first documented by the Australian National Joint Replacement Registry in early 2008. The evidence presented clearly demonstrated a very high rate of failure concerning this device. Australia withdrew this device from the market in December 2009. Researchers from a British study also reported problems with the metal-on-metal implants causing adverse soft tissue reactions resulting from the friction of the metal-on-metal surfaces. These patients showed higher rates of wear and tear and soft tissue damage. The United States Food and Drug Administration did not participate in a recall despite this information. Hospitals and hip surgeons in the United States had been warned about the defects of this device, but continued to use it anyway, until DEPUY voluntarily recalled the product in March, 2010.
Subscribe to:
Posts (Atom)